Search by Drug Name or NDC

    NDC 00078-0569-12 EXTAVIA Details

    EXTAVIA

    EXTAVIA is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is .

    Product Information

    NDC 00078-0569
    Product ID 0078-0569_21e70358-f7a8-4b98-8f6c-d2d4cf020a94
    Associated GPIs 62403060506420
    GCN Sequence Number 062602
    GCN Sequence Number Description interferon beta-1b KIT 0.3 MG SUBCUT
    HIC3 H0E
    HIC3 Description AGENTS TO TREAT MULTIPLE SCLEROSIS
    GCN 98376
    HICL Sequence Number 008537
    HICL Sequence Number Description INTERFERON BETA-1B
    Brand/Generic Brand
    Proprietary Name EXTAVIA
    Proprietary Name Suffix n/a
    Non-Proprietary Name Interferon beta-1b
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Novartis Pharmaceuticals Corporation
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125290
    Listing Certified Through 2024-12-31

    Package

    NDC 00078-0569-12 (00078056912)

    NDC Package Code 0078-0569-12
    Billing NDC 00078056912
    Package 15 BLISTER PACK in 1 CARTON (0078-0569-12) / 1 KIT in 1 BLISTER PACK (0078-0569-61) * 3 mL in 1 VIAL, SINGLE-USE * 1.2 mL in 1 SYRINGE
    Marketing Start Date 2009-08-14
    NDC Exclude Flag N
    Pricing Information N/A